BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29305973)

  • 1. Peroxidasin is regulated by the epithelial-mesenchymal transition master transcription factor Snai1.
    Sitole BN; Mavri-Damelin D
    Gene; 2018 Mar; 646():195-202. PubMed ID: 29305973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-30a negatively regulates TGF-β1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1.
    Zhou Q; Yang M; Lan H; Yu X
    Am J Pathol; 2013 Sep; 183(3):808-19. PubMed ID: 23831330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI1.
    Qu X; Xu C; Yang W; Li Q; Tu S; Gao C
    Cancer Biomark; 2024; 39(3):231-243. PubMed ID: 38217587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition.
    Al-Hattab DS; Safi HA; Nagalingam RS; Bagchi RA; Stecy MT; Czubryt MP
    Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H658-H668. PubMed ID: 29906225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.
    Tyszka-Czochara M; Lasota M; Majka M
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29337896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone methyltransferase SETDB1 inhibits TGF-β-induced epithelial-mesenchymal transition in pulmonary fibrosis by regulating SNAI1 expression and the ferroptosis signaling pathway.
    Liu T; Xu P; Ke S; Dong H; Zhan M; Hu Q; Li J
    Arch Biochem Biophys; 2022 Jan; 715():109087. PubMed ID: 34801472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
    Cheng KY; Hao M
    Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mithramycin inhibits epithelial-to-mesenchymal transition and invasion by downregulating SP1 and SNAI1 in salivary adenoid cystic carcinoma.
    Li J; Gao H; Meng L; Yin L
    Tumour Biol; 2017 Jun; 39(6):1010428317708697. PubMed ID: 28631560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin 13 gene is epigenetically suppressed during transforming growth factor-β1-induced epithelial-mesenchymal transition in a human keratinocyte cell line.
    Hatta M; Miyake Y; Uchida K; Yamazaki J
    Biochem Biophys Res Commun; 2018 Feb; 496(2):381-386. PubMed ID: 29326042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial to Mesenchymal Transition in Human Mesothelial Cells Exposed to Asbestos Fibers: Role of TGF-β as Mediator of Malignant Mesothelioma Development or Metastasis via EMT Event.
    Turini S; Bergandi L; Gazzano E; Prato M; Aldieri E
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.
    Zinn R; Otterbein H; Lehnert H; Ungefroren H
    Cells; 2019 Dec; 8(12):. PubMed ID: 31817229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch signaling mediates TGF-β1-induced epithelial-mesenchymal transition through the induction of Snai1.
    Matsuno Y; Coelho AL; Jarai G; Westwick J; Hogaboam CM
    Int J Biochem Cell Biol; 2012 May; 44(5):776-89. PubMed ID: 22330899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toosendanin, a natural product, inhibited TGF-β1-induced epithelial-mesenchymal transition through ERK/Snail pathway.
    Luo W; Liu X; Sun W; Lu JJ; Wang Y; Chen X
    Phytother Res; 2018 Oct; 32(10):2009-2020. PubMed ID: 29952428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway.
    Chen Z; Li S; Huang K; Zhang Q; Wang J; Li X; Hu T; Wang S; Yang R; Jia Y; Sun H; Tang F; Zhou H; Shen J; Ma D; Wang S
    Hum Pathol; 2013 Oct; 44(10):2097-105. PubMed ID: 23791009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the TGF-β1-induced protein expression of SNAI1 and N-cadherin by miR-199a.
    Suzuki T; Mizutani K; Minami A; Nobutani K; Kurita S; Nagino M; Shimono Y; Takai Y
    Genes Cells; 2014 Sep; 19(9):667-75. PubMed ID: 25041364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 18 is necessary for initiation of TGF-β1-induced epithelial-mesenchymal transition in breast epithelial cells.
    Jung H; Kim B; Moon BI; Oh ES
    Mol Cell Biochem; 2016 Dec; 423(1-2):21-28. PubMed ID: 27734227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition.
    Sundararajan V; Tan M; Tan TZ; Ye J; Thiery JP; Huang RY
    Sci Rep; 2019 Jun; 9(1):8295. PubMed ID: 31165775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Ets-1 transcription factor in inducing matrix metalloproteinase-2 expression by epithelial-mesenchymal transition in human squamous carcinoma cells.
    Taki M; Verschueren K; Yokoyama K; Nagayama M; Kamata N
    Int J Oncol; 2006 Feb; 28(2):487-96. PubMed ID: 16391805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.